Birdshot retinochoroidopathy review

Clovis Arcoverde Freitas-Neto; Sutasinee Boonsopon; Swetha Dhanireddy; Armin Maghsoudlou; Sukhum Silpa-Archa; Charles Stephen Foster

doi:10.5935/0004-2749.20150016

Birdshot retinochoroidopathy review

Clovis Arcoverde Freitas-Neto
, Sutasinee Boonsopon
, Swetha Dhanireddy
, Armin Maghsoudlou
, Sukhum Silpa-Archa
, Charles Stephen Foster

Massachusetts Eye Research and Surgery Institution
Ocular Immunology and Uveitis Foundation
Hospital de Olhos Santa Luzia
Rangsit University
Harvard Medical School

Research output: Contribution to journal › Review article › peer-review

4 Citations (Scopus)

Abstract

Birdshot retinochoroidopathy (BSRC) is a distinct type of posterior uveitis originally described in the 1940s. Its characteristics include minimal anterior segment inflammation and diffuse posterior choroidopathy with vitritis and retinal vasculitis. The precise etiology of this disease is yet to be elucidated. However, various treatment modalities have been employed with the ultimate goal of durable remission of this vision threatening intraocular disease. The purpose of this review is not only to emphasize the importance of recognizing BSRC, but also to discuss the new discoveries, immune mediators, current and new therapies, and techniques applied to monitor and accomplish disease remission.

Original language	English
Pages (from-to)	56-61
Number of pages	6
Journal	Arquivos Brasileiros de Oftalmologia
Volume	78
Issue number	1
DOIs	https://doi.org/10.5935/0004-2749.20150016
Publication status	Published - 2015
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Chorioretinitis/diagnosis
Chorioretinitis/drug therapy
Drug combination
Electroretinography
Tomography
Uveitis
optical coherence
posterior

Access to Document

10.5935/0004-2749.20150016

Cite this

@article{0469d8451b8444cbba4f9d842afa9d5e,

title = "Birdshot retinochoroidopathy review",

abstract = "Birdshot retinochoroidopathy (BSRC) is a distinct type of posterior uveitis originally described in the 1940s. Its characteristics include minimal anterior segment inflammation and diffuse posterior choroidopathy with vitritis and retinal vasculitis. The precise etiology of this disease is yet to be elucidated. However, various treatment modalities have been employed with the ultimate goal of durable remission of this vision threatening intraocular disease. The purpose of this review is not only to emphasize the importance of recognizing BSRC, but also to discuss the new discoveries, immune mediators, current and new therapies, and techniques applied to monitor and accomplish disease remission.",

keywords = "Chorioretinitis/diagnosis, Chorioretinitis/drug therapy, Drug combination, Electroretinography, Tomography, Uveitis, optical coherence, posterior",

author = "Freitas-Neto, \{Clovis Arcoverde\} and Sutasinee Boonsopon and Swetha Dhanireddy and Armin Maghsoudlou and Sukhum Silpa-Archa and Foster, \{Charles Stephen\}",

year = "2015",

doi = "10.5935/0004-2749.20150016",

language = "English",

volume = "78",

pages = "56--61",

journal = "Arquivos Brasileiros de Oftalmologia",

issn = "0004-2749",

publisher = "Conselho Brasileiro De Oftalmologia",

number = "1",

}

TY - JOUR

T1 - Birdshot retinochoroidopathy review

AU - Freitas-Neto, Clovis Arcoverde

AU - Boonsopon, Sutasinee

AU - Dhanireddy, Swetha

AU - Maghsoudlou, Armin

AU - Silpa-Archa, Sukhum

AU - Foster, Charles Stephen

PY - 2015

Y1 - 2015

N2 - Birdshot retinochoroidopathy (BSRC) is a distinct type of posterior uveitis originally described in the 1940s. Its characteristics include minimal anterior segment inflammation and diffuse posterior choroidopathy with vitritis and retinal vasculitis. The precise etiology of this disease is yet to be elucidated. However, various treatment modalities have been employed with the ultimate goal of durable remission of this vision threatening intraocular disease. The purpose of this review is not only to emphasize the importance of recognizing BSRC, but also to discuss the new discoveries, immune mediators, current and new therapies, and techniques applied to monitor and accomplish disease remission.

AB - Birdshot retinochoroidopathy (BSRC) is a distinct type of posterior uveitis originally described in the 1940s. Its characteristics include minimal anterior segment inflammation and diffuse posterior choroidopathy with vitritis and retinal vasculitis. The precise etiology of this disease is yet to be elucidated. However, various treatment modalities have been employed with the ultimate goal of durable remission of this vision threatening intraocular disease. The purpose of this review is not only to emphasize the importance of recognizing BSRC, but also to discuss the new discoveries, immune mediators, current and new therapies, and techniques applied to monitor and accomplish disease remission.

KW - Chorioretinitis/diagnosis

KW - Chorioretinitis/drug therapy

KW - Drug combination

KW - Electroretinography

KW - Tomography

KW - Uveitis

KW - optical coherence

KW - posterior

UR - https://www.scopus.com/pages/publications/84923407358

U2 - 10.5935/0004-2749.20150016

DO - 10.5935/0004-2749.20150016

M3 - Review article

C2 - 25714542

AN - SCOPUS:84923407358

SN - 0004-2749

VL - 78

SP - 56

EP - 61

JO - Arquivos Brasileiros de Oftalmologia

JF - Arquivos Brasileiros de Oftalmologia

IS - 1

ER -

Birdshot retinochoroidopathy review

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this